Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 Update

International Journal of Clinical Oncology

Volumn 13, Issue 1, 2008, Pages 33-41

  Ishihara, Kazuyuki ^a   Saida, Toshiaki ^b   Otsuka, Fujio ^c   Yamazaki, Naoya ^d  

^a Inst Anal Prog Factors Skin Can   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Japanese population; Malignant melanoma; Statistical survey; Survival rate; TNM classification

Indexed keywords

BETA INTERFERON; CISPLATIN; DACARBAZINE; LACTATE DEHYDROGENASE; NIMUSTINE; TAMOXIFEN; VINCRISTINE; VINDESINE;

ACTINIC KERATOSIS; AGE DISTRIBUTION; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; FOLLOW UP; HEALTH SURVEY; HUMAN; JAPAN; KAPLAN MEIER METHOD; LACTATE DEHYDROGENASE BLOOD LEVEL; LENTIGINOUS MELANOMA; LOG RANK TEST; LYMPH NODE DISSECTION; MELANOMA; MYCOSIS FUNGOIDES; OVERALL SURVIVAL; PAGET NIPPLE DISEASE; PREVALENCE; PRIORITY JOURNAL; SEX RATIO; SKIN CANCER; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; JAPAN; MALE; MELANOMA; MIDDLE AGED; PRECANCEROUS CONDITIONS; PREVALENCE; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 40149090144     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-007-0751-1     Document Type: Article

References (16)

1. Kawamura T, Ikeda S, Nishiwaki S, et al. (1974) The status of malignant skin tumors in Japan shown by the TNM Classification Prognosis Investigation (in Japanese). Hifuka no Rinsho 16:385-398
2. Ishihara K, Ikeda S, Mori S, et al. (1989) Prognostic factors for malignant melanoma (in Japanese). Skin Cancer 4:349-360
3. Ishihara K (1994) Nationwide survey of malignant melanoma (in Japanese). Skin Cancer (special issue) 9:159-167
4. Ishihara K (1995) Statistics of malignant melanoma. Gann Monograph on Cancer Research 43:147-157
5. Ishihara K (1977) Statistics of malignant melanoma in Japan (in Japanese). Skin Cancer 12:18-25
6. Ishihara K, Saida T, Yamamoto A (2000) Nationwide survey for incidence of malignant melanoma in 1992 to 1998 (in Japanese). Skin Cancer 15:7-14
7. Ishihara, Saida T, Yamamoto A, et al. (2001) Updated statistical data for malignant melanoma in Japan. Int J Clin Oncol 6: 109-116
8. Ishihara K (2006) Statistics and prognostic factors for malignant skin tumors in Japan: malignant melanoma. Skin Cancer 20: 234-248
9. Streetly A, Markowe H (1995) Changing trends in the epidemiology of malignant melanoma: gender differences and their implications for public health. Int J Epidemiol 24:897-907
10. Milo Y, Tamir G, Robinpour M, et al. (1995) Epidemiology and prognostic factors in cutaneous malignant melanoma. Harefuah 15: 745-751
11. Cummings FJ, McDonald CJ, Calabresi P (1988) Melanoma. In: Calabresi P, Schein P, Rosenberg SA (eds) Medical oncology II. Macmillan, New York, pp 636-663
12. Sobin LH, Wittekind CH (eds) (2002) UICC TNM classification of malignant tumors, 6th edn. Springer, Berlin Heidelberg Tokyo New York
13. Balch CM, Buzaid AC, Atkins MB, et al. (2000) A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer 88:1484-1491
14. Balch CM, Buzaid AC, Soong S-J, et al. (2001) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635-3648
15. Joseph G, Polk HC (1997) Malignant melanoma. In: Benjamin D, Daniel MS (eds) Oncology. Churchill Livingstone, Philadelphia, pp 119-122
16. Cochran AJ, Roberts AA, Saida T (2003) The place of lymphatic mapping and sentinel node biopsy in oncology. Int J Clin Oncol 8:139-150